Taro Pharmaceutical Industries Ltd (DELISTED) (TARO:DL)
42.97
0.00 (0.00%)
USD |
NYSE |
Jun 25, 16:00
Taro Pharmaceutical Industries Revenue (Quarterly): 164.94M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 164.94M |
December 31, 2023 | 157.14M |
September 30, 2023 | 148.20M |
June 30, 2023 | 158.89M |
March 31, 2023 | 146.59M |
December 31, 2022 | 139.20M |
September 30, 2022 | 130.50M |
June 30, 2022 | 156.66M |
March 31, 2022 | 143.26M |
December 31, 2021 | 138.98M |
September 30, 2021 | 131.99M |
June 30, 2021 | 147.11M |
March 31, 2021 | 148.35M |
December 31, 2020 | 140.14M |
September 30, 2020 | 142.84M |
June 30, 2020 | 117.63M |
March 31, 2020 | 174.94M |
December 31, 2019 | 147.68M |
September 30, 2019 | 160.85M |
June 30, 2019 | 161.30M |
March 31, 2019 | 179.92M |
December 31, 2018 | 176.38M |
September 30, 2018 | 158.97M |
June 30, 2018 | 154.62M |
March 31, 2018 | 175.22M |
Date | Value |
---|---|
December 31, 2017 | 155.46M |
September 30, 2017 | 169.92M |
June 30, 2017 | 161.32M |
March 31, 2017 | 196.41M |
December 31, 2016 | 220.40M |
September 30, 2016 | 228.79M |
June 30, 2016 | 233.78M |
March 31, 2016 | 265.07M |
December 31, 2015 | 258.34M |
September 30, 2015 | 212.06M |
June 30, 2015 | 215.28M |
March 31, 2015 | 244.18M |
December 31, 2014 | 237.70M |
September 30, 2014 | 250.83M |
June 30, 2014 | 130.23M |
March 31, 2014 | 187.18M |
December 31, 2013 | 213.60M |
September 30, 2013 | 205.32M |
June 30, 2013 | 153.20M |
March 31, 2013 | 165.13M |
December 31, 2012 | 185.70M |
September 30, 2012 | 160.97M |
June 30, 2012 | 159.15M |
March 31, 2012 | 145.14M |
December 31, 2011 | 148.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
117.63M
Minimum
Jun 2020
174.94M
Maximum
Mar 2020
146.39M
Average
146.85M
Median
Revenue (Quarterly) Benchmarks
InspireMD Inc | 1.739M |
BiomX Inc | -- |
Alpha Tau Medical Ltd | -- |
Pluri Inc | 0.096M |
Holdco Nuvo Group DG Ltd | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 15.08M |
Total Expenses (Quarterly) | 156.16M |
EPS Diluted (Quarterly) | 0.40 |
Enterprise Value | 735.66M |
Gross Profit Margin (Quarterly) | 52.98% |
Profit Margin (Quarterly) | 9.14% |
Earnings Yield | 3.35% |
Operating Earnings Yield | 1.33% |
Normalized Earnings Yield | 3.345 |